$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Isoforms of human pregnancy-associated protein-E 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C12N-009/50
  • C12N-015/79
  • C12N-001/21
  • C12N-005/10
  • C12Q-001/37
출원번호 US-0827998 (2001-04-06)
발명자 / 주소
  • Gu, Yizhong
  • Shannon, Mark E.
출원인 / 주소
  • Amersham PLC
대리인 / 주소
    Fish & Neave
인용정보 피인용 횟수 : 4  인용 특허 : 152

초록

The invention provides isolated nucleic acids that encode three novel isoforms of human pregnancy associated plasma protein E, hPAPP-E, and fragments thereof, vectors for propagating and expressing PAPP-E nucleic acids, host cells comprising the nucleic acids and vectors of the present invention, pr

대표청구항

1. An isolated nucleic acid comprising a nucleotide sequence selected from the group consisting of: (i) the nucleotide sequence of SEQ ID NO:1; (ii) the nucleotide sequence of SEQ ID NO:2; (iii) a nucleotide sequence that is a degenerate variant of the nucleotide sequence of SEQ ID NO:2; (iv) a s

이 특허에 인용된 특허 (152)

  1. Tkachuk Zenovy (Kiev SUX) Kvasyuk Eugeny (Kiev SUX) Matsuka Gennady (Kiev SUX) Mikhailopulo Igor (Kiev SUX), (2′-5′) oligoadenylate analogues useful as inhibitors of host-v5.-graft response.
  2. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Constance DEX), 2′,5′-phosphorothioate oligoadenylates and their covalent conjugates with polylysine.
  3. Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR) Stirchak Eugene P. (Corvallis OR), Alpha-morpholino ribonucleoside derivatives and polymers thereof.
  4. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Aminoalkylphosphorothioamidate oligonucleotide deratives.
  5. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Aminoalkylphosphotriester oligonucleotide derivatives.
  6. Geysen Hendrik (Knoxfield AUX), Antigenically active amino acid sequences.
  7. Ramos Rogerio Tadeu ; Stephenson Kenneth,GBX, Apparatus and tool using tracers and singles point optical probes for measuring characteristics of fluid flow in a hydrocarbon well and methods of processing resulting signals.
  8. Fodor Stephen P. A. (Palo Alto CA) Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA) Stryer Lubert (Stanford CA), Array of oligonucleotides on a solid substrate.
  9. Fodor Stephen P.A. ; Stryer Lubert ; Read J. Leighton ; Pirrung Michael C., Arrays of materials attached to a substrate.
  10. De Mesmaeker Alain (Kaenerkinden CHX) Lebreton Jacques (Marseilles FRX) Waldner Adrian (Allschwil CHX) Cook Phillip D. (Carlsbad CA), Backbone modified oligonucleotide analogs.
  11. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA) Morvan Francois (Montpellier FRX), Backbone modified oligonucleotide analogs and solid phase synthesis thereof.
  12. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (San Marcos CA) Vasseur Jean J. (San Marcos CA) Debart Francoise (Montpellier FRX), Backbone modified oligonucleotide analogues.
  13. Sanghvi Yogesh S. (San Marcos CA) Cook Phillip D. (Vista CA), Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling.
  14. Matteucci Mark D. (Burlingame CA) Cao Xiaodong (Carlsbad CA), Binding compentent oligomers containing unsaturated 3′,5′and 2′,5′linkages.
  15. Rometsch Rainer (Wildberg DEX), Blood pressure measuring device and a method of controlling the cuff pressure in a blood pressure measuring device.
  16. Capecchi Mario R. (Salt Lake City UT) Thomas Kirk R. (Salt Lake City UT), Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and.
  17. Capecchi Mario R. (Salt Lake City UT) Thomas Kirk R. (Salt Lake City UT), Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and.
  18. Capecchi Mario R. (Salt Lake City UT) Thomas Kirk R. (Salt Lake City UT), Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and.
  19. Capecchi Mario R. ; Thomas Kirk R., Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same.
  20. Kmiec Eric B., Chimeric mutational vectors having non-natural nucleotides.
  21. Kmiec Eric B., Chimeric mutational vectors having non-natural nucleotides.
  22. Holloman William K. ; Kmiec Eric B., Compositions and methods to promote homologous recombination in eukaryotic cells and organisms.
  23. Kmiec Eric B., Compounds and methods for site directed mutations in eukaryotic cells.
  24. Kmiec Eric B., Compounds and methods for site directed mutations in eukaryotic cells.
  25. Cook Phillip D. (San Marcos CA) Teng Kelly (San Diego CA), Conjugated 4′-desmethyl nucleoside analog compounds.
  26. Hodges Thomas K. (West Lafayette IN) Lyznik Leszek A. (West Lafayette IN), Controlled modification of eukaryotic genomes.
  27. Malone Robert W. ; Malone Jill G., DNA vaccines for eliciting a mucosal immune response.
  28. Tyagi Sanjay ; Kramer Fred R. ; Lizardi Paul M.,MXX, Detectably labeled dual conformation oligonucleotide probes, assays and kits.
  29. Nadeau James G. ; Pitner J. Bruce ; Schram James L. ; Linn C. Preston ; Vonk Glenn P. ; Walker G. Terrance, Detection of nucleic acids by fluorescence quenching.
  30. Popp Hans-Joachim,DEX, Device and process for detecting and identifying wearable user identification units.
  31. Miyazaki Nagao (Osaka-Sayama JPX), Device for measuring action force of wheel and device for measuring stress of structure.
  32. Flesselles Jacques (Orleans FRX) Buisson Jean (Orleans FRX) Morin Michel (Orleans FRX) Boittin Jean-Pierre (Fleury-les-Aubrais FRX) Tripot Pierre (Orleans FRX) Vallee Claude (Chaingy FRX), Device for measuring the draft of smoking articles such as cigarettes and combined measuring apparatus including such a.
  33. Okumura Hidemasa,JPX ; Shibata Kazuyoshi,JPX ; Takeuchi Yukihisa,JPX, Device for measuring viscosity and device for measuring characteristics of fluid.
  34. Carson Dennis A. ; Raz Eyal, Devices for administration of naked polynucleotides which encode biologically active peptides.
  35. Baxter Anthony D. (Northwich GB2) Baylis Eric K. (Stockport GB2) Collingwood Stephen P. (Westhoughton GB2) Taylor Roger J. (Stretford GB2) De Mesmaeker Alain (Kanerkinden CHX) Schmit Chantal (Basel C, Dinucleoside phosphinates and their pharmaceutical compositions.
  36. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Konstanz DEX), Dual action 2′,5′-oligoadenylate antiviral derivatives and uses thereof.
  37. Suhadolnik Robert J. (Roslyn PA) Pfleiderer Wolfgang (Constance DEX), Encapsulated 2′,5′-phosphorothioate oligoadenylates.
  38. Savazzi Ezio,ITX, Equipment for measuring the dimensions of tools of machines for mechanical working.
  39. Amano Kazuhiko,JPX ; Uebaba Kazuo,JPX ; Ishiyama Hitoshi,JPX, Exercise intensity measuring device and exercise quantity measuring device.
  40. Ward William W. ; Chalfie Martin, Expression of a gene for a modified green-fluorescent protein.
  41. Cormack Brendan P. ; Valdivia Raphael H. ; Falkow Stanley, FACS-optimized mutants of the green fluorescent protein (GFP).
  42. Cormack Brendan P. ; Valdivia Raphael H. ; Falkow Stanley, FACS-optimized mutants of the green fluorescent protein (GFP).
  43. Kosaka Tokihiro,JPX ; Nakamoto Hiroyuki,JPX ; Kubota Fumio,JPX, Flow cytometer.
  44. Levy Douglas R., Gel electrophoresis apparatus having CAM-activated clamp and methods of use.
  45. Kucherlapati Raju ; Jakobovits Aya ; Klapholz Sue ; Brenner Daniel G. ; Capon Daniel J., Generation of Xenogenetic antibodies.
  46. Kucherlapati Raju ; Jakobovits Aya ; Kalpholz Sue ; Brenner Daniel G. ; Capon Daniel J., Generation of xenogeneic antibodies.
  47. Cook Phillip D. (Carlsbad CA) Sanghvi Yogesh S. (Carlsbad CA), Heteroatomic oligonucleoside linkages.
  48. Teng Kelly (San Diego CA) Sanghvi Yogesh S. (San Marcos CA) Cook Phillip Dan (San Marcos CA), Heteroatomic oligonucleoside linkages.
  49. Koster Claus,DEX, High-mass detector with high mass-resolution for time-of-flight mass spectrometers.
  50. Zelmanovic David ; Colella Gregory M. ; Hetherington Edward J. ; Chapman Evelyn Sabrinah ; Paseltiner Lynn, Highly sensitive, accurate, and precise automated method and device for identifying and quantifying platelets and for determining platelet activation state using whole blood samples.
  51. Kucherlapati Raju ; Jakobovits Aya ; Brenner Daniel G. ; Capon Daniel J. ; Klapholz Sue, Human antibodies derived from immunized xenomice.
  52. Kucherlapati Raju ; Jakobovits Aya ; Klapholz Sue ; Brenner Daniel G. ; Capon Daniel J., Human antibodies derived from immunized xenomice.
  53. Morgan Susan Adrienne,GBX ; Emtage John Spencer,GBX ; Bodmer Mark William,GBX ; Athwal Diljeet Singh,GBX, Humanized antibodies.
  54. Carter Paul J. ; Presta Leonard G., Humanized antibodies and methods for making them.
  55. Zolotukhin Sergei ; Muzyczka Nicholas ; Hauswirth William W., Humanized green fluorescent protein genes and methods.
  56. Zolotukhin Sergei ; Muzyczka Nicholas ; Hauswirth William W., Humanized green fluorescent protein genes and methods.
  57. Queen Cary L. ; Selick Harold E., Humanized immunoglobulins and methods of making the same.
  58. Bot Adrian ; Bona Constantin, Immunization of infants.
  59. Carter Paul J. ; Presta Leonard G., Immunoglobulin variants.
  60. Selden Richard F ; Treco Douglas ; Heartlein Michael W., In vivo production and delivery of erythropoietin for gene therapy.
  61. Felgner Philip L. (Rancho Santa Fe CA) Wolff Jon A. (Madison WI) Rhodes Gary H. (Leucadia CA) Malone Robert W. (Chicago IL) Carson Dennis A. (Del Mar CA), Induction of a protective immune response in a mammal by injecting a DNA sequence.
  62. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  63. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke She L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  64. Cohen Jack S. (Bethesda MD) Neckers Len (Bethesda MD) Stein Cy (Gaithersburg MD) Loke Shee L. (Wheaton MD) Shinozuka Kazuo (Kazo JPX), Inhibitors for replication of retroviruses and for the expression of oncogene products.
  65. Agrawal Sudhir (Shrewsbury MA) Tang Jin-Yan (Shrewsbury MA), Linear aminoalkylphosphoramidate oligonucleotide derivatives.
  66. 3394032 ; 19680700 ; Danner ; 136 86, Long wavelength engineered fluorescent proteins.
  67. Tsien Roger Y. ; Cubitt Andrew B. ; Heim Roger ; Ormo Mats F.,SEX ; Remington S. James, Long wavelength engineered fluorescent proteins.
  68. Bremer Joannes G. (Eindhoven NLX), Measuring device for determining an absolute position of a movable element and scale graduation element suitable for use.
  69. Kmiec Eric B. ; Cole-Strauss Allyson D., Method and oligonucleobase compounds for curing diseases caused by mutations.
  70. Livak Kenneth J. (San Jose CA) Flood Susan J. A. (Fremont CA) Marmaro Jeffrey (Foster City CA), Method for detecting nucleic acid amplification using self-quenching fluorescence probe.
  71. Goelet Philip ; Knapp Michael R. ; Anderson Stephen, Method for determining nucleotide identity through extension of immobilized primer.
  72. Chappel Scott C. (Jamaica Plain MA), Method for the modification of the expression characteristics of an endogenous gene of a given cell line.
  73. Geysen Hendrik M. (Menzies Creek AUX), Method for the use and synthesis of peptides.
  74. Geysen Hendrik Mario,AUX, Method for the use and synthesis of peptides.
  75. Geysen Hendrik M. (Knoxfield AUX), Method of determining antigenically active amino acid sequences.
  76. Kucherlapati Raju ; Jakobovits Aya, Method of making transgenic mice lacking endogenous heavy chains.
  77. Light Susan ; Queen Cary, Method of preventing acute rejection following solid organ transplantation.
  78. Carson Dennis A. ; Raz Eyal, Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory.
  79. Kmiec Eric B. ; Cole-Strauss Allyson ; Yoon Kyonggeun, Methods and compounds for curing diseases caused by mutations.
  80. Carson Dennis A. (Del Mar CA) Raz Eyal (San Diego CA), Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleoti.
  81. Carson Dennis A. ; Raz Eyal ; Howell Meredith L., Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptide.
  82. Morrison Sherie L. ; Herzenberg Leonard A. ; Oi Vernon T., Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric.
  83. Bradley Allan (Houston TX) Davis Ann (Houston TX) Hasty Paul (Houston TX), Methods for the genetic modification of endogenous genes in animal cells by homologous recombination.
  84. Schrader John W. (Vancouver CAX), Methods for the production of proteins with a desired function.
  85. Holloman William K. ; Kmiec Eric B., Methods to promote homologous recombination in eukaryotic cells and organisms.
  86. Studnicka Gary M., Modified antibody variable domains.
  87. Studnicka Gary M., Modified antibody variable domains.
  88. Studnicka Gary M. ; Little ; II Roger G. ; Fishwild Dianne M. ; Kohn Fred R., Modified antibody variable domains.
  89. Studnicka Gary M., Modified antibody variable domains and therapeutic uses thereof.
  90. Tsien Roger Y. (La Jolla CA) Heim Roger (Del Mar CA), Modified green fluorescent proteins.
  91. Tsien Roger Y. ; Heim Roger, Modified green fluorescent proteins.
  92. Tsien Roger Y. ; Heim Roger, Modified green fluorescent proteins.
  93. Matteucci Mark (Burlingame CA) Jones Robert J. (Daly City CA) Munger John (San Francisco CA), Modified internucleoside linkages having one nitrogen and two carbon atoms.
  94. Beaton Graham (Boulder CO) Fisher Eric F. (Boulder CO), Modified oligonucleotides and intermediates useful in nucleic acid therapeutics.
  95. Pavlakis George N. ; Gaitanaris George A. ; Stauber Roland H. ; Vournakis John N., Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence.
  96. Michaels Mark, Mutants of the green fluorescent protein having improved fluorescent properties at 37.degree..
  97. Ts\o Paul O. P. (2117 Folkstone Rd. Lutherville MD 21093) Miller Paul S. (225 Hopkins Rd. Baltimore MD 21212), Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof.
  98. Li Xiaomao,CAX ; Ewashysyn Mary E.,CAX ; Klein Michel H.,CAX, Nucleic acid respiratory syncytial virus vaccines.
  99. Li Xiaomao,CAX ; Ewasyshyn Mary E.,CAX ; Sambhara Suryaprakash,CAX ; Klein Michel H.,CAX, Nucleic acid respiratory syncytial virus vaccines.
  100. Li Xiaomao,CAX ; Ewasyshyn Mary E.,CAX ; Sambhara Suryaprakash,CAX ; Klein Michel H.,CAX, Nucleic acid respiratory syncytial virus vaccines.
  101. Baird Charles (77 Olive St. Oak View CA 93022) Plum William B. (611 Colina Vista Ventura CA 93003), Oil well survey tool.
  102. Meyer ; Jr. Rich B. (Woodinville WA) Adams A. David (Snohomish WA) Petrie Charles R. (Woodinville WA), Oligo (aa 상세보기
  • Letsinger Robert L. (Wilmette IL) Gryaznov Sergei M. (San Mateo CA), Oligodeoxyribonucleotides including 3′-aminonucleoside-phosphoramidate linkages and terminal 3′-amino groups.
  • Sanghvi Yogesh S. (Carlsbad CA) Cook Phillip D. (Carlsbad CA), Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms.
  • Hecht Sidney M. (Charlottesville VA), Oligonucleotide N-alkylphosphoramidates.
  • Bischofberger Norbert (San Carlos CA) Kent Ken (Mountain View CA) Wagner Rick (Burlingame CA) Buhr Chris (Daly City CA) Lin Kuei-Ying (Fremont CA), Oligonucleotide analogs capable of passive cell membrane permeation.
  • Benner Steven A. (Grossmannstrasse 16 ; #7 CH-8049 Zurich CHX), Oligonucleotide analogs containing sulfur linkages.
  • Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  • Matteucci Mark (Burlingame CA), Oligonucleotide analogs with novel linkages.
  • Huie Edward M. (Wilmington DE) Trainor George L. (Wilmington DE), Oligonucleotide analogs with sulfamate linkages.
  • Weis Alexander Ludvik (Berwyn PA) Hausheer Frederick Herman (San Antonio TX) Chaturvedula Prasad Venkata Chala (Exton PA) Delecki Daniel Joseph (Radnor PA) Cavanaugh ; Jr. Paul Francis (West Chester , Oligonucleotide analogues containing phosphate diester linkage substitutes, compositions thereof, and precursor dinucleo.
  • Chaturvedula Prasad Venkata Chala (Exton PA), Oligonucleotide dimers with amide linkages replacing phosphodiester linkages.
  • Tullis Richard H. (La Jolla CA), Oligonucleotide therapeutic agent and method of making same.
  • Cook Phillip D. (San Marcos CA) Hoke Glenn (Mt. Airy MD), Oligonucleotides having phosphorothioate linkages of high chiral purity.
  • Froehler Brian (Belmont CA), Oligonucleotides with inverted polarity.
  • Imbach Jean-Louis (Montpellier FRX) Gosselin Gilles J. M. (Montpellier FRX), Oligonucleotides, a process for preparing the same and their application as mediators of the action of interferon.
  • Spielvogel Bernard F. (Raleigh NC) Sood Anup (Durham NC) Hall Iris H. (Chapel Hill NC) Shaw Barbara R. (Durham NC), Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates.
  • Nielsen Peter E. (Hjortevanget 509 DK 2980 Kokkedal DKX) Buchardt Ole (Sondergardsvej 73 DK 3500 Vaerlose DKX) Egholm Michael (Johnstrup Alle 3 DK 1923 Frederiksberg DKX) Berg Rolf H. (Strandvaenget , Peptide nucleic acids.
  • Buchardt ; deceased Ole,DKX ; Buchardt ; legal representative by Dorte,DKX ; Egholm Michael ; Nielsen Peter Eigil,DKX ; Berg Rolf Henrik,DKX, Peptide nucleic acids having amino acid side chains.
  • Buchardt ; deceased Ole,DKX ; Buchardt ; representative by Dorte,DKX ; Egholm Michael ; Nielsen Peter Eigil,DKX ; Berg Rolf Henrik,DKX, Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility.
  • Maddry Joseph A. (Birmingham AL) Reynolds Robert C. (Birmingham AL) Secrist John A. (Birmingham AL) Montgomery John A. (Birmingham AL) Crooks Peter A. (Lexington KY), Polynucleotide analogs containing sulfonate and sulfonamide internucleoside linkages.
  • Caruthers Marvin H. (Boulder CO) Marshall William S. (Boulder CO) Brill Wolfgang (Freiburg DEX) Nielsen John (Horsholm DKX), Polynucleotide phosphorodithioate.
  • Caruthers Marvin H. (Boulder CO) Marshall William S. (Boulder CO), Polynucleotide phosphorodithioates.
  • Queen Cary L. (Los Altos CA) Schneider William P. (Mountain View CA) Selick Harold E. (Belmont CA), Polynucleotides encoding improved humanized immunoglobulins.
  • Ohtomo Fumio,JPX ; Kobayashi Haruhiko,JPX ; Yamaguchi Shinji,JPX, Position detection surveying device.
  • Capecchi Mario R. (Salt Lake City UT) Thomas Kirk R. (Salt Lake City UT), Positive-negative selection methods and vectors.
  • Weis Alexander L. (Berwyn PA) Saha Ashis K. (Frazer PA) Hausheer Frederick H. (San Antonio TX), Process of linking nucleosides with a siloxane bridge.
  • Surani Azim M. (Cambridge GB3) Neuberger Michael S. (Cambridge GB3) Bruggemann Marianne (Cambridge GB3), Production of antibodies from transgenic animals.
  • Skoultchi Arthur I., Production of proteins using homologous recombination.
  • Lonberg Nils (San Francisco CA) Kay Robert M. (San Francisco CA), Ransgenic non-human animals for producing heterologous antibodies.
  • Hsu Ching-Hsiang,TWX ; Chua Kaw-Yan,TWX ; Tao Mi-Hua,TWX ; Hsieh Kue-Hsiung,TWX, Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic.
  • Lizardi Paul M.,MXX, Rolling circle replication reporter systems.
  • Kool Eric T., Rolling circle synthesis of oligonucleotides and amplification of select randomized circular oligonucleotides.
  • Livak Kenneth J. ; Flood Susan J.A. ; Marmaro Jeffrey ; Mullah Khairuzzaman Bashar, Self-quenching fluorescence probe.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Sequence-specific binding polymers for duplex nucleic acids.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Sequence-specific binding polymers for duplex nucleic acids.
  • Agrawal, Sudhir; Tang, Jinyan, Site-specific functionalization of oligodeoxynucleotides for non-radioactive labelling.
  • Loewy Zvi Gerald ; Singh Bawa, Solid support with attached molecules.
  • Treco Douglas ; Heartlein Michael W. ; Selden Richard F, Targeted introduction of DNA into primary or secondary cells and their use for gene therapy.
  • Treco Douglas ; Heartlein Michael W. ; Selden Richard F, Targeted introduction of DNA into primary or secondary cells and their use for gene therapy and protein production.
  • Krimpenfort Paulus J. A. (Amsterdam NLX) Berns Antonius J. M. (Spaarndam NLX), Transgenic mice depleted in a mature lymphocytic cell-type.
  • Lonberg Nils (San Francisco CA) Kay Robert M. (San Francisco CA), Transgenic non-human animals capable of producing heterologous antibodies.
  • Lonberg Nils ; Kay Robert M., Transgenic non-human animals capable of producing heterologous antibodies.
  • Lonberg Nils ; Kay Robert M., Transgenic non-human animals capable of producing heterologous antibodies.
  • Lonberg Nils (San Francisco CA) Kay Robert M. (San Francisco CA), Transgenic non-human animals capable of producing heterologous antibodies of various isotypes.
  • Lonberg Nils (San Francisco CA) Kay Robert M. (San Francisco CA), Transgenic non-human animals capable of producing heterologous antibodies of various isotypes.
  • Lonberg Nils ; Kay Robert M., Transgenic non-human animals capable of producing heterologous antibodies of various isotypes.
  • Lonberg Nils (Redwood City CA) Kay Robert M. (San Francisco CA), Transgenic non-human animals for producing heterologous antibodies.
  • Lonberg Nils ; Kay Robert M., Transgenic non-human animals for producing heterologous antibodies.
  • Lonberg Nils ; Kay Robert M., Transgenic non-human animals for producing heterologous antibodies.
  • Summerton, James E.; Weller, Dwight D., Uncharged morpholino-based polymers having achiral intersubunit linkages.
  • Summerton James E. (Corvallis OR) Weller Dwight D. (Corvallis OR), Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages.
  • 이 특허를 인용한 특허 (4)

    1. Freier, Susan M.; Bhanot, Sanjay, Antisense modulation of GCCR expression.
    2. Freier, Susan M.; Bhanot, Sanjay, Antisense modulation of GCCR expression.
    3. Oxvig,Claus; Overgaard,Michael Toft, Pregnancy-associated plasma protein-A2 (PAPP-A2).
    4. Oxvig, Claus; Overgaard, Michael Toft, Pregnancy-associated plasma protein-A2 (PAPP-A2) polynucleotides.
    섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로